KELLERMAN DONALD J 4
4 · Zosano Pharma Corp · Filed Oct 19, 2021
Insider Transaction Report
Form 4
KELLERMAN DONALD J
VP, Clinical Dev & Med Affairs
Transactions
- Award
Stock Option (Right to Buy)
2021-10-15+20,000→ 20,000 totalExercise: $0.63Exp: 2031-10-14→ Common Stock (20,000 underlying) - Award
Common Stock
2021-10-15+10,000→ 60,337 total
Footnotes (3)
- [F1]Represents Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the completion of performance vesting.
- [F2]Includes 10,000 RSUs which are subject to performance vesting.
- [F3]The shares subject to the stock option vest and become exercisable in accordance with a performance vesting schedule.